Trial Profile
Phase II Trial of Cisplatin Combined With Oral TS-1 in Patients With Advanced Solid Tumors With Different Degrees of Liver Dysfunction
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Apr 2022
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 12 Apr 2022 Planned primary completion date changed from 20 Dec 2021 to 20 Dec 2022.
- 10 May 2018 New trial record